JPRN-jRCT2080223363已完成2 期
Phase II Clinical Study of BTDS in Japanese Patients with Cancer Pain
Mundipharma K.K.0 个研究点目标入组 70 人开始时间: 2016年11月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with cancer
排除标准
- •- Patients whom the investigator/subinvestigator judges might not be appropriate for the study due to skin sensitivity, etc. at the application site
- •- Patients with severe respiratory depression or respiratory dysfunction
研究者
相似试验
已完成
2 期
A clinical study of KDT-3594 in Japanese patients with early Parkinson's disease.Parkinson's diseaseJPRN-jRCT2031210089Shimizu Yoshitaka6
未知
1 期
A Two-Part Study in Japanese Patients With Advanced or Metastatic NSCLC. Open-Label Phase I to Assess the Safety & Tolerability of AZD2171 in Combination With Pac/Carb, Then a Phase II, Randomised, Double-Blind Study to Assess the Efficacy of AZD2171 Alone and in Combination With AZD2171 and Pac/CarbCarcinoma, Non-Small-Cell LungJPRN-jRCT2080220478AstraZeneca
已完成
2 期
Japanese phase II study in untreated patients with CD20 positive B-cell non-Hodgkin's lymphoma evaluating safety of 90-minute infusion of rituximab.CD20 positive follicular lymphoma or diffuse large B-cell lymphoma.JPRN-jRCT2080223607ZENYAKU KOGYO CO., LTD.33
已完成
不适用
Assessment of Beta-Blocker Treatment in Japanese Patients with Chronic Heart FailureChronic heart failureJPRN-UMIN000000548J-CHF Study Group480
已完成
1 期
Phase 1 study of DS-6051bAdvanced solid malignant tumors harboring either a ROS1 or NTRK fusion geneJPRN-jRCT2080223057DAIICHI SANKYO CO., LTD.15